Prelude Therapeutics Inc
PRLD—
Prelude Therapeutics IncPRLD$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$-1.29
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$12.14M
Net income
$-99.50M
Net margin
-819.6%
Gross margin
—
Dividends & financials
Prelude Therapeutics Inc (PRLD) reported revenue of $12.14M and net income of $-99.50M, or $-1.29 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.